Baxter International, US0673431090

Baxter International Stock - Early tender results on 2026 and 2027 notes

Published on 06/18/2026 at 16:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Baxter International has reported early tender results for its 2.600% senior notes due 2026 and 1.915% senior notes due 2027, as the healthcare group continues reshaping its balance sheet ahead of its planned kidney-care spin-off.

Baxter International, US0673431090, Illustration mit AI erstellt.
Baxter International, US0673431090, Illustration mit AI erstellt.

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 16:23 CET. Details in the imprint.

Baxter International (US0673431090) has disclosed early tender results for its 2.600% senior notes due 2026 and 1.915% senior notes due 2027. The liability-management step was announced in a Business Wire release this morning, as the group continues to refine its capital structure.

Go deeper

All news and analysis on Baxter International stock

Key figures, background and further reporting on Baxter International stock can be found in the dedicated topic area on ad-hoc-news.de.

What Baxter reported on its notes

According to a Business Wire release dated 06/17/2026, Baxter reported early tender results for its 2.600% senior notes due 2026 and 1.915% senior notes due 2027.

The company is pursuing this tender offer as part of ongoing balance-sheet management, against the backdrop of portfolio reshaping and the planned spin-off of its kidney-care business.

Thursday focus on the chart

Baxter International shares closed at $19.39 on 06/17/2026, down 5.2% on the day, according to GuruFocus data.

TradingKey shows the stock at $19.69 at the 06/17 close, with a beta of 0.65 and a risk assessment score of 6.65 within the healthcare equipment and supplies industry.

The product behind the stock

Baxter International generates most of its revenue from medical products such as intravenous (IV) solutions, infusion pumps and injectable drugs, alongside renal-care therapies and clinical nutrition offerings for hospitals and outpatient settings.

Where the stock trades today

Baxter International shares (US0673431090) trade on the New York Stock Exchange at $19.69 as of 06/17/2026, 16:00 ET.

Baxter International at a glance

  • Company: Baxter International Inc.
  • ISIN: US0673431090
  • WKN: 853815
  • Ticker: BAX
  • Venue: NYSE
  • Price (as of 06/17/2026, 16:00 ET): 19.69 USD
  • Market cap: 10,000,000,000 USD (as of 06/17/2026)
  • Sector / Industry: Health Care / Health Care Equipment & Supplies
  • Index membership: S&P 500
  • Next earnings date: not officially scheduled

More on Baxter International stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US0673431090 | BAXTER INTERNATIONAL | boerse | 69573654 | bgmi